AUROBINDO PHARMA LTD. - Outcome of Board Meeting

Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 06, 2015, inter alia, accorded revised approval for raising funds through issue of Equity / GDRs / ADRs / FCCBs or any other equity related instruments upto an amount of USD 600 million or rupee equivalent thereof subject to approval of the shareholders of the Company and other necessary approvals. The Board has also decided to seek approval of the shareholders through postal ballot for the above purpose.